Archives
-
Inhaled RNA Disrupts Tumor Collagen to Boost Lung Cancer Imm
2026-07-01
This study introduces an inhalable lipid nanoparticle system co-delivering mRNA encoding anti-DDR1 antibody fragments and siRNA targeting PD-L1 to reshape the lung tumor microenvironment. By disrupting collagen fiber alignment and relieving immunosuppression, the strategy significantly enhances T cell infiltration and antitumor efficacy, with implications for broader solid tumor immunotherapy.
-
Direct BAK Activation: SJ572946 as a Tool for Apoptosis Rese
2026-07-01
Sekar et al. (2022) present SJ572946, a small molecule discovered via fragment-based screening that directly binds and activates the pro-apoptotic effector BAK, initiating mitochondrial apoptosis. This work provides a valuable tool for dissecting BAK-specific apoptotic pathways and offers new perspectives for targeted cancer research.
-
Mitomycin C: Antitumor Antibiotic for DNA Replication Inhibi
2026-06-30
Mitomycin C is a potent antitumor antibiotic that inhibits DNA replication via covalent DNA crosslinking, leading to cytotoxic effects in proliferating cells. Its mechanism enables apoptosis signaling research, especially in p53-independent and TRAIL-sensitized cancer models. APExBIO provides a highly characterized form (A4452) for reproducible cancer research.
-
2'-O-Methyladenosine Nucleoside: Applied Workflows & Assay O
2026-06-30
2'-O-Methyladenosine nucleoside enables precise RNA modification and purine metabolism studies with robust, quantifiable readouts. Explore advanced UHPLC-MS/MS workflows, troubleshooting insights, and domain-bridging applications that maximize the value of this APExBIO research reagent.
-
Endothelial STING-JAK1 Axis: Normalizing Tumor Vasculature a
2026-06-29
This article analyzes a recent study uncovering the critical role of endothelial STING-JAK1 interaction in tumor vasculature normalization and antitumor immune response. The findings offer new mechanistic insights that refine understanding of the cGAS-STING pathway in cancer immunotherapy, with implications for optimizing STING agonist applications.
-
Selective Spectrophotometric Analysis of Phenolic β-Lactam A
2026-06-29
The referenced study introduces two rapid, selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics, including amoxicillin in complex formulations with dicloxacillin. These protocols offer accessible, cost-effective alternatives to chromatographic assays, enhancing analytical precision in antibiotic research and quality control.
-
EZ Cap™ EPO mRNA (ψUTP): Redefining Erythropoietin mRNA Stab
2026-06-28
Discover how EZ Cap™ EPO mRNA (ψUTP) empowers advanced erythropoiesis and neuroprotection studies. Explore the molecular advantages of this high-stability, low-immunogenicity human erythropoietin mRNA, with unique insights into translational applications.
-
4-Hydroxytamoxifen: Protocol Guidance for Cancer and Cardiac
2026-06-27
4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator designed for in vitro and in vivo applications, including breast and prostate cancer research and cardiac myocyte studies. It is optimally used in workflows requiring DMSO solubility and strict storage conditions, but is unsuitable for protocols that depend on aqueous or ethanol-based solvents.
-
Ganetespib (STA-9090): Optimizing Hsp90 Inhibition in Cancer
2026-06-26
Ganetespib (STA-9090) delivers unmatched potency and selectivity for Hsp90 inhibition, accelerating workflows in advanced cancer research and tumor biology. This article details protocol enhancements, troubleshooting insights, and innovative applications that distinguish Ganetespib as a benchmark tool for dissecting oncogenic pathways and chaperone dependencies.
-
MOB1A/B Loss Disrupts Intestinal Homeostasis via BMP/TGF-β A
2026-06-26
The study demonstrates that depleting MOB1A/B in intestinal epithelial cells disrupts stem cell maintenance and differentiation by suppressing Wnt signaling and enhancing BMP/TGF-β pathways. Partial rescue using a BMP signaling pathway inhibitor highlights the pivotal role of balanced pathway interactions in epithelial tissue integrity.
-
Palmitic acid (Hexadecanoic Acid): Technical Guidance & QC
2026-06-25
Palmitic acid (hexadecanoic acid, SKU N2456) addresses the need for a high-purity, well-characterized saturated long-chain fatty acid in studies of lipid metabolism, protein palmitoylation, and metabolic disorder research. It is unsuited for aqueous-based protocols or prolonged solution storage, making precise handling and workflow control essential for reliable results.
-
KU-55933: ATM Kinase Inhibitor Linking DNA Damage to Metabol
2026-06-25
Explore how KU-55933, a potent ATM kinase inhibitor, bridges DNA damage response with cellular metabolism and heart failure signaling. This article offers a unique, integrative perspective for advanced cancer research and translational disease modeling.
-
PDGF-BB in Pulmonary Hypertension: Mechanisms, Models, and T
2026-06-24
This thought-leadership article explores how murine recombinant PDGF-BB, a potent mitogen, is revolutionizing translational research in pulmonary hypertension by linking smooth muscle cell proliferation to mitochondrial reprogramming. We integrate mechanistic insights from recent lactylation studies, provide strategic assay guidance, and discuss how APExBIO's validated PDGF-BB enables robust experimentation for disease modeling and therapeutic innovation.
-
Spleen-Targeted Neoantigen mRNA Vaccine Induces TLS in HCC
2026-06-23
Lin et al. report a spleen-targeted neoantigen mRNA vaccine (STNvac) that drives robust antitumor immunity in hepatocellular carcinoma by eliciting ISG15+ CD8+ T cells and promoting tertiary lymphoid structure formation. This work highlights the potential for organ-targeted mRNA vaccine strategies to overcome immunologically cold tumor microenvironments.
-
Central Pathways in Opioid-Induced Mechanical Hypersensitivi
2026-06-23
Yin et al. (2024) identify a central brain-to-spinal pathway regulating morphine-induced mechanical hypersensitivity and tolerance in mice, challenging peripheral-centric models of opioid side effects. Their mechanistic dissection of the lPBNMOR+ / PVHDyn+ / SDHKOR-GABA circuit provides a new framework for targeting opioid-induced hyperalgesia and tolerance.